⏳ Fetching live dividend data...
Home › Calculator › GBT Dividend Calculator 2026
Global Blood Therapeutics, Inc. · NASDAQ
Price: $68.49 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
GBT is not a dividend-focused stock
GBT pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Global Blood Therapeutics, Inc. (GBT) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
Global Blood Therapeutics, Inc. (GBT) is a biopharmaceutical firm dedicated to discovering, developing, and providing therapies for patients suffering from sickle cell disease (SCD) who currently lack adequate treatment options. Its marketed product, Oxbryta tablets, offers a once-daily, oral treatment for SCD. Furthermore, GBT is conducting a Phase IIa clinical trial to assess the safety and pharmacokinetic profile of single and multiple doses of Oxbryta in younger SCD patients, including adolescents and children. In its development pipeline, inclacumab stands as a primary candidate – a novel human monoclonal antibody currently undergoing Phase IIIa clinical trials. This investigational drug aims to diminish the occurrence of painful vaso-occlusive crises and subsequent hospitalizations. Also in early-stage development (Phase I) is GBT601, a compound designed to inhibit hemoglobin polymerization. The company holds a licensing and collaborative agreement with Syros Pharmaceuticals, Inc. focused on identifying, advancing, and commercializing treatments for both SCD and beta thalassemia. Additionally, GBT collaborates with Sanofi S.A. on two separate early-stage research initiatives targeting SCD. Established in 2011, Global Blood Therapeutics, Inc. maintains its headquarters in South San Francisco, California.
No. Global Blood Therapeutics, Inc. (GBT) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. GBT has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GBT position with:
Real after-tax yield depends on where you live and how you hold GBT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
GBT pays quarterly — 4 times per year. Ex-div: —.
How GBT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GBT sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2022-10-05 | 5,600 | — | — | ||
| D-Return | 2022-10-05 | 5,600 | — | — | ||
| D-Return | 2022-10-05 | 5,600 | — | — | ||
| D-Return | 2022-10-05 | 3,600 | — | — | ||
| D-Return | 2022-10-05 | 30,000 | — | — | ||
| D-Return | 2022-10-05 | 7,500 | — | — | ||
| D-Return | 2022-10-05 | 5,600 | — | — | ||
| D-Return | 2022-10-05 | 5,600 | — | — | ||
| D-Return | 2022-10-05 | 18,120 | — | — | ||
| G-Gift | 2022-09-28 | 22,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Compare GBT with peers: GBT vs ALPN · GBT vs CBAY · GBT vs ISEE
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GBT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Global Blood Therapeutics, Inc. (GBT) is currently trading at $68.49, 6% below its 52-week high. It does not currently pay a regular dividend.
Global Blood Therapeutics, Inc. (GBT) is a healthcare stock trading at $68.49. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only — not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever